Quanterix (QTRX) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Quanterix (QTRX) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 70.6% versus a loss of 82.4%. Over five years, RPID leads with a -94.4% price change compared with -95.4% for QTRX. Quanterix is the larger company by market cap ($93.1 million vs $37.4 million), about 2.5 times the size, while Rapid Micro Biosystems is growing revenue faster (+19.7% vs +1.1%).
Quanterix converts more of its revenue into profit, with a net margin of -77.1% versus -140.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QTRX | RPID |
|---|---|---|
| Share price | $1.96 | $0.735 |
| Market cap | $93.06M | $37.37M |
| 1-day change | -3.45% | -0.04% |
| YTD return | -69.18% | -74.66% |
| 1-year return | -70.57% | -82.37% |
| 5-year return | -95.45% | -94.41% |
| EPS (TTM) | $-2.34 | $-1.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $138.90M | $33.59M |
| Revenue growth (YoY) | +1.07% | +19.74% |
| Net income (latest FY) | $-107.15M | $-47.12M |
| Gross margin | 46.77% | — |
| Operating margin | -90.38% | -141.10% |
| Net margin | -77.14% | -140.30% |
| 52-week high | $8.77 | $4.94 |
| 52-week low | $1.77 | $0.58 |
| Distance from 52-week high | -77.65% | -85.12% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +69.90% | +682.31% |
| Average volume | 721.60K | 577.05K |
| Shares outstanding | 47.48M | 46.34M |
| Employees | 450 | 171 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Quanterix is about 2.5 times larger than Rapid Micro Biosystems by market value ($93.06M vs $37.37M).
- QTRX has outperformed RPID by 11.8 percentage points over the past year.
- Quanterix is more profitable, keeping -77.1 cents of every revenue dollar as net income versus -140.3 cents for Rapid Micro Biosystems.
- Rapid Micro Biosystems grew revenue faster in its latest fiscal year (+19.74% vs +1.07%).
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
About Rapid Micro Biosystems
RPID stock →Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees
QTRX vs RPID FAQ
Which is bigger, Quanterix or Rapid Micro Biosystems?
Quanterix (QTRX) is larger, with a market capitalization of $93.06M compared with $37.37M for Rapid Micro Biosystems (RPID).
Which stock has performed better over the past year, QTRX or RPID?
QTRX returned -70.57% over the past 12 months, compared with -82.37% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are Quanterix and Rapid Micro Biosystems in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.